Treatment of Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Deficiency
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03712930 |
|
Recruitment Status :
Terminated
(Sponsor's decision to revisit the development approach for prostate cancer.)
First Posted : October 19, 2018
Last Update Posted : September 23, 2020
|
Sponsor:
BeiGene
Information provided by (Responsible Party):
BeiGene
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | August 6, 2020 |
| Actual Study Completion Date : | August 6, 2020 |